What is the first‑line oral antibiotic for acute bacterial paronychia, and what are the alternatives for patients with penicillin allergy or risk of community‑associated MRSA?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antibiotic for Paronychia

For acute bacterial paronychia requiring antibiotic therapy, dicloxacillin 500 mg four times daily or cephalexin 500 mg four times daily is the first-line oral treatment for methicillin-susceptible Staphylococcus aureus (MSSA). 1

First-Line Oral Antibiotics for Acute Bacterial Paronychia

For presumed MSSA infection:

  • Dicloxacillin 500 mg orally four times daily is the oral agent of choice for methicillin-susceptible strains 1
  • Cephalexin 500 mg orally four times daily is an equally effective alternative 1
  • Duration: 5-10 days depending on clinical response 1

Alternatives for Penicillin Allergy

For patients with penicillin allergy (excluding immediate hypersensitivity reactions):

  • Cephalexin 500 mg orally four times daily can be used if the allergy is not an immediate hypersensitivity reaction 1
  • Clindamycin 300-450 mg orally three times daily is appropriate for true penicillin allergy 1

Important caveat: Clindamycin has potential for cross-resistance and emergence of resistance in erythromycin-resistant strains, with inducible resistance possible in MRSA 1

Coverage for Community-Associated MRSA

When CA-MRSA is suspected or confirmed (purulent drainage, failed initial therapy, systemic toxicity, or known MRSA colonization):

Oral options include:

  • Clindamycin 300-450 mg orally three times daily 1
  • Trimethoprim-sulfamethoxazole (TMP-SMX) 1-2 double-strength tablets twice daily 1
  • Doxycycline or minocycline 100 mg twice daily (avoid in children <8 years) 1
  • Linezolid 600 mg twice daily (expensive, reserve for resistant cases) 1

Critical consideration: If streptococcal coverage is also needed alongside MRSA coverage, use clindamycin alone OR combine TMP-SMX or a tetracycline with a beta-lactam (e.g., amoxicillin) 1

Pediatric Dosing

For children requiring systemic antibiotics:

  • Dicloxacillin: 25-50 mg/kg/day in 4 divided doses 1
  • Cephalexin: 25-50 mg/kg/day in 3-4 divided doses 1
  • Clindamycin: 20-30 mg/kg/day in 3 divided doses orally 1
  • TMP-SMX: 8-12 mg/kg/day (based on trimethoprim component) in 2 divided doses 1

Common Pitfalls to Avoid

Do not routinely prescribe systemic antibiotics for all paronychia cases - many acute bacterial paronychias respond to incision and drainage alone without antibiotics 2, 3, 4

Antibiotic-resistant acute paronychia may have non-bacterial causes including viral (herpetic whitlow), fungal, drug-induced, or inflammatory etiologies 2, 5

Chronic paronychia (≥6 weeks duration) is typically an irritant dermatitis, not a bacterial infection - systemic antibiotics are ineffective and should not be used routinely 2, 4

Consider culture and sensitivity testing when there is severe infection, systemic illness, failure to respond to initial treatment, or concern for MRSA 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Paronychia].

Presse medicale (Paris, France : 1983), 2014

Research

Acute and chronic paronychia of the hand.

The Journal of the American Academy of Orthopaedic Surgeons, 2014

Research

Acute and Chronic Paronychia.

American family physician, 2017

Research

Clinical and cytologic features of antibiotic-resistant acute paronychia.

Journal of the American Academy of Dermatology, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.